This Article Full Text (PDF) All Versions of this Article: 0272989X07309644v1 28/1/44    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Barton, P. M. Articles by Delaney, B. C. Search for Related Content PubMed PubMed Citation Articles by Barton, P. M. Articles by Delaney, B. C. Social Bookmarking                   What's this?

A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States

Health Economics Facility University of Birmingham, UK

Paul Moayyedi, PhD

Department of Gastroenterology, McMaster University, Hamilton, Ontario, Canada

Nicholas J. Talley, MD

Center for Enteric Neurosciences and Translational Epidemiological Research (CENTER), Mayo Clinic College of Medicine, Rochester, Minnesota, Department of Medicine, University of Sydney, Sydney, Australia

Nimish B. Vakil, MD

University of Wisconsin Medical School, Milwaukee, Wisconsin

Brendan C. Delaney, MD

Department of Primary Care and General Practice University of Birmingham, UK, b.c.delaney{at}bham.ac.uk

Background. The ``gold-standard'' evidence of effectiveness for a clinical practice guideline is the randomized controlled trial (RCT), although RCTs have a limited ability to explore potential management strategies for a chronic disease where these interact over time. Modeling can be used to fill this gap, and models have become increasingly complex, with both dynamic sampling and representation of second-order uncertainty to provide more precise estimates. However, both simulation modeling and probabilistic sensitivity analysis are rarely used together. The objective of this study was to explore uncertainty in controversial areas of the 2005 American Gastroenterology Association position statement on the management of dyspepsia. Methods. Individual sampling model, incorporating a second-order probabilistic sensitivity analysis. Population. US adult patients presenting in primary care with dyspepsia. Interventions compared: empirical acid suppression, test and treat for Helicobacter pylori, initial endoscopy, acid suppression then endoscopy, test and treat then proton pump inhibitor (PPI) then endoscopy. Outcomes. Cost-effectiveness, quality-adjusted life years, and costs in US dollars from a societal perspective, measured over a 5-year period. Data sources: mainly Cochrane meta-analyses. Results. Endoscopy was dominated at all ages by other strategies. PPI therapy was the most cost-effective strategy in 30-year-olds with a low prevalence of H. pylori. In 60-year-olds, H. pylori test and treat was the most cost-effective option. Conclusions. Acid suppression alone was more cost-effective than either endoscopy or H. pylori test and treat in younger dyspepsia patients with a low prevalence of infection.

Key Words: computer simulation • dyspepsia • cost-benefit analysis

This version was published on January 1, 2008

Medical Decision Making, Vol. 28, No. 1, 44-55 (2008)
DOI: 10.1177/0272989X07309644


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?